Xenografts with neuroblastoma cells were treated with the chemotherapeutic drug Temozolomide (under clinical investigation for treatment of refractory/relapsed neuroblastoma: NCT02308527 or NCT01467986) and the ALK inhibitor (ALKi) Ceritinib34,35. This evidence concerns the gene ALK and neuroblastoma.